Dwaipayan Mukherjee

Dwaipayan Mukherjee

AbbVie Inc - Chicago / United States
Medical and Health Sciences / Pharmacology
AD Scientific Index ID: 4849192
-
person_outline Dwaipayan Mukherjee's MOST POPULAR ARTICLES
1-) Physiologically‐based pharmacokinetic models for evaluating membrane transporter mediated drug–drug interactions: current capabilities, case studies, future opportunities, and …KS Taskar, V Pilla Reddy, H Burt, MM Posada, M Varma, M Zheng, ...Clinical Pharmacology & Therapeutics 107 (5), 1082-1115, 2020632020
2-) Physiologically-based toxicokinetic modeling of zearalenone and its metabolites: Application to the Jersey girl studyD Mukherjee, SG Royce, JA Alexander, B Buckley, SS Isukapalli, ...PLoS One 9 (12), e113632, 2014482014
3-) Clinical implications of altered drug transporter abundance/function and PBPK modeling in specific populations: an ITC perspectiveX Chu, B Prasad, S Neuhoff, K Yoshida, JS Leeder, D Mukherjee, ...Clinical Pharmacology & Therapeutics 112 (3), 501-526, 2022412022
4-) Modeling population exposures to silver nanoparticles present in consumer productsSG Royce, D Mukherjee, T Cai, SS Xu, JA Alexander, Z Mi, L Calderon, ...Journal of Nanoparticle Research 16, 1-25, 2014402014
5-) Dose adjustment of venetoclax when co-administered with posaconazole: clinical drug–drug interaction predictions using a PBPK approachS Bhatnagar, D Mukherjee, AH Salem, D Miles, RM Menon, JP GibbsCancer Chemotherapy and Pharmacology, 1-10, 2021272021